Obesity in the United States has reached astonishing proportions with age-adjusted obesity prevalence estimates to be 32% for men and 36% for women [1] . Furthermore, obesity has been shown to be a significant risk factor in the development of osteoarthritis, though such association seems to be stronger in knees compared to hips [2] [3] [4] [5] [6] . Subsequently, an increasing demand for total hip (THA) or knee arthroplasty (TKA) can be expected among obese patients [7] [8] [9] . Fehring, et al. quantified this trend by demonstrating an increase in the number of obese patients undergoing total joint arthroplasty (TJA) from 30.4% in 1990 to 52.1% in 2005 [10] .
Understanding the risks and benefits for an obese total joint patient cannot be underestimated, especially under growing surgeon accountability to deliver low-cost, high value care. The majority of the current literature would indicate higher perioperative complication rates following TJA in the obese population including longer operative times, increased wound complications/infections, and increased hospital length of stay (LOS) and cost [11] [12] [13] [14] . However, obesity risk assessment is a complicated condition that is compounded by other associated major comorbidities (diabetes mellitus, hypertension, coronary artery disease) that independently increase surgical risk [15] . Thus, a need exists to better define and classify obesity that more clearly and effectively identifies TJA perioperative risks and outcomes.
Obesity is classically defined by body mass index (BMI) calculated by the formula: BMI = weight(kilograms)/height(meters) 2 . Despite its common use, BMI fails to distinguish fat mass from lean mass, does not account for distribution of fat mass, nor does it allow for individual population or gender differences. Percent body fat (PBF) (total mass of fat divided by total weight) represents a more patient-specific measure that does distinguish weight associated with muscle versus weight associated with adipose tissue [16] . Accordingly, a lower PBF (and thus more lean muscle mass) logically better corresponds to a patient's superior fitness level. Additionally, recent clinical data have shown higher PBF to be a more sensitive and precise predictor of surgical site infection than BMI in a broad range of elective surgical procedures [17] .
The aim of this research was to analyze the relationship of PBF to acute perioperative complications and outcomes after TJA compared to BMI in a prospective cohort study. Since PBF potentially represents a more accurate patient-specific measure than BMI, we hypothesized that PBF would be better associated with perioperative risks and outcomes following total hip and knee arthroplasty, especially in the surgeries performed on obese patients.
Materials and Methods

Patient Population
This study retrospectively reviewed a prospective cohort of 316 patients undergoing primary TKA (n = 148) or THA (n = 168) at Duke University Medical Center from April 1, 2012 to March 1, 2013. All patients presented for elective joint arthroplasty with end-stage degenerative joint disease of the hip or knee that markedly limited function and failed to improve with conservative treatment. Patients were included in the study if they had undergone preoperative BMI and PBF determination. Percentage body fat was determined by bioelectrical impedance analysis (BIA) prior to arthroplasty. Exclusion criteria included those with a history of cognitive impairment, neurological deficiencies, unable to stand without the use of an assistive device, or undergoing revision arthroplasty. The Institutional Review Board approved the study prior to investigation initiation.
Obesity Classification
Preoperative height and weight were measured to calculate each patient's BMI. Body composition (PBF) was determined using a bioelectrical impedance model, the InBody230 (GE Healthcare Lunar, Fig. 1 . Example of a body composition report indicating the patient's body mass index (BMI) and percent body fat (PBF).
Madison, WI). There was no specific control for the patient's hydration status except that all measurements were performed during standard clinic hours. The process of PBF measurement involves the patient standing on metal footpad scale and gripping BIA handles. After inputting the patient's age and height, total body water, lean mass and fat mass are calculated and a report is instantly printed (Fig. 1) . These reports were then stored in a protected electronic database with a patient identifier in order to retrospectively collect perioperative complication and outcomes data following surgery. It is important to note that PBF can be calculated through a variety of measures (hydrodensitometry, dual energy x-ray absorptiometry, anthropometric measures); however, body-fat estimation by current BIA has validated correlation against such measures [18] [19] [20] .
Perioperative outcome measures were reviewed separately based on overall BMI and PBF. The patients were also viewed in relation to a standard BMI or PBF obesity classification system (Table 1 ). There is no universally accepted definition of morbid obesity based on PBF; however, the American College of Sports Medicine (ACSM) has historically established normative standards accounting for gender-specific and age-related changes in body composition [16] . Accordingly, male patients with a PBF N 25 and females PBF N 38 were classified as obese.
Data Collection and Statistical Analysis
Clinical data were collected through retrospective chart reviews of each patient's pre-operative history and physical examination, anesthesia and operative reports, discharge summaries, and acute postoperative clinical follow-up. Routine descriptive statistics were calculated according to each obesity classification. Further analysis was performed using independent samples t-test or one-way ANOVA and all statistical significance was established at P b 0.05. For each of the dichotomous variables, a receiver operator curve was utilized to identify cut points of PBF and BMI where a significant positive likelihood existed.
Results
Of the 316 patients assessed in the study, 257 patients classified as obese by PBF compared to 180 patients (144 obese, 36 morbidly obese) by BMI underwent primary THA or TKA. The average age at surgery for the obese patients was comparable at 60.8 and 61.7 years for BMI and PBF, respectively. The indication for total joint arthroplasty was predominantly for osteoarthritis (OA) with the largest percentage of OA in the morbidly obese and obese cohorts of both BMI and PBF. The comorbidity profile of obese patients as defined by American Society of Anesthesiologists (ASA) score of 3 (severe systemic disease) was higher for BMI (76.7%) than PBF (59.9%).
Operative time, estimated blood loss (EBL), adverse perioperative hospital events, blood transfusion for clinically symptomatic anemia (defined by hematocrit b 25 L/L and signs of anemia including tachycardia, orthostasis, or light-headedness), and length of stay (LOS) N3 days were highest in the obese and morbidly obese cohorts; however, the rates were similar when comparing obesity as defined by classifications of BMI and PBF ( Table 2 ). The rate of obese patients defined by PBF with hospital LOS N3 days (66.9%) was much greater than obese patients defined by BMI (32.2%). Six knees underwent manipulation under anesthesia (MUA) for arthrofibrosis (b90°of flexion at 6 weeks postoperatively). Only two patients (33.3%) were defined as obese by BMI compared to four (66.7%) obese patients by PBF.
Significant differences were most apparent when comparing the cohort based on overall PBF and BMI. PBF was significantly (P b 0.05) higher in those who underwent blood transfusion (mean ± standard deviation; 41.9 ± 12.0 versus 37.7 ± 9.1), had longer length of stay (LOS) N3 days (41.5 ± 9.5 versus 34.2 ± 8.7), and were discharged to an extended care facility rather than home (41.8 ± 10.1 versus 36. 4 ± 8.6) . No significant differences existed on these risks when examining the group based on BMI. Both BMI (34.6 ± 6.2 kg/m 2 versus 31.6 ± 6.0 kg/m 2 ) and PBF (41.5 ± 9.5 versus 37.7 ± 9.3) were significantly higher in the patients with postoperative hospital based adverse events.
Additional analysis of these dichotomous variables through a receiver operator curve (ROC) demonstrated significant clinical cut points when examining PBF. Specifically, a PBF of 43.5 was associated with a 2.4 × greater likelihood (P = 0.02) of needing a blood transfusion, a PBF of 36.5 with 1.9× greater likelihood (P b 0.01) for a LOS N3 days, and a PBF of 36.0 demonstrated a 1.4× greater likelihood (P b 0.01) for discharge to extended care facility (Table 3) . Although a higher BMI was also associated with a slightly increased likelihood of these risks, there was not a statistically significant cut point.
Discussion
The prevalence of obese patients undergoing elective total joint arthroplasty is rapidly increasing [10] . Even within the present cohort, 57 and 81% of patients undergoing arthroplasty were defined as obese by BMI and PBF, respectively. There remains an invaluable need to better define and understand the impact of obesity on perioperative risks and outcomes following TJA. Although the BMI classification is widely used to define obesity, body composition represents a patientspecific measure with potential to better risk-stratify and predict outcomes in overweight individuals undergoing TJA.
Obesity must be examined in the context of coexisting associated comorbidities which themselves can be independent risk factors for perioperative complications [21] . The ASA score was utilized to evaluate the degree of comorbidities in this cohort and the prevalence of comorbidities was indeed higher in both BMI and PBF obesity groups. The rate of ASA 3 scores for obese patients by BMI was actually higher than obese patients by PBF (76.7 versus 59.9%); however, the overall perioperative medical complication rates were similar between the groups. While higher BMIs appear to be associated with higher ASA scores, perhaps PBF may be an important variable to consider in the context of obesity comorbidities and the risk of medical complications.
When the study sample was stratified according to BMI and PBF obesity classifications, the overall operative (EBL, operative time), perioperative (adverse hospital events, blood transfusion, discharge disposition), and acute postoperative complications (wound drainage, medical treatments, MUAs, dislocation, reoperation) were higher among the obese than the normal groups. The rates of these complications were similar when comparing the obese groups as defined by BMI and PBF. One notable exception was the dramatically higher rate of increased LOS N3 days for the obese by PBF (66.9%) compared to obese by BMI (32.2%). Several recent studies have also demonstrated the importance of obesity BMI thresholds associated with increased complications and increased LOS [12, 14] . Although PBF does not further sub-classify obese from morbidly obese patients by definition, the results appear to show higher postoperative complication rates in the obese group as defined by the current PBF classification system.
Aside from obesity stratification, only PBF was significant higher and demonstrated increased likelihood for postoperative blood transfusion, LOS N3 days, and discharge to an extended care facility. Increased LOS has been previously documented in obese patients undergoing TKA and THA [13] . Schwarzkopf et al. demonstrated a LOS increase by 13.8% for each 5-unit increase in BMI above 45. Additionally, higher costs exist in the rehabilitation setting for obese patients after TKA [22] . Conversely, Batsis et al. demonstrated no significant differences in length of stay and hospital resource use between obesity classifications [23] . Although aforementioned studies use BMI criterion, our results seem to indicate that higher PBF is actually a better determinant than higher BMI on these important outcomes. Such cost-provoking outcomes must be considered as true complications as these outcomes may be used as "quality" measures under the current era of healthcare policy change.
The limitations of the study include the retrospective review of outcomes, short-term follow-up, and need for a larger patient sample size to determine the power of significant findings. Body composition analysis by BIA can vary according to hydration status (eating, drinking, and exercise) and there was no specific control for hydration other than a normal preoperative assessment within standard clinic hours. However, according to Houtkooper et al., such variability is estimated to be small (b 1-2%) when the same BIA instrument and identical measurement techniques were used such as in the present study [19] . Furthermore, the accuracy and reproducibility of measurements have consistently been shown to be superior to lower cost skinfold-thickness measurements and validated against the goldstandard densitometry measurements [20, 23] . The interpretation of results specifically comparing BMI and PBF classification groups was difficult given that no standard value exists for degrees of obesity within PBF. Nonetheless, this remains the first study that utilizes PBF as an alternative definition of obese patients undergoing elective total knee or hip arthroplasty.
The results suggest that body composition as defined by PBF may be a more effective measure than BMI for determining perioperative risks and acute outcomes associated with TJA performed in obese patients. Further research is needed to understand the relationship obesity (defined by BMI or PBF) has on total joint arthroplasty. The present cohort of patients will be followed for a longer-term to identify additional significant clinical and functional outcome differences between obese BMI and PBF patients.
